CLINICAL_TRIALS
trial_result
· 2017-04-28
Clinical Trial Update: Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS [Phase 1]
Summary
Phase 1 trial evaluating intravenous adipose-derived mesenchymal stem cells for amyotrophic lateral sclerosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Royan Institute | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: COMPLETED